Lassa Fever: Nigeria, Others To Commence Vaccine Clinical Trials
The Lassa fever vaccine clinical trials are set to commence in Nigeria, Sierra Leone and Liberia, the Public Affairs of the United States Diplomatic Mission to Nigeria said. The disclosure was made in a statement on Monday, saying the European and Developing Countries Clinical Trial Partnership and the Coalition for Epidemic Preparedness Innovations has awarded €22.8 million to the International AIDS Vaccine Initiative to conduct a Phase IIB trial of the IAVI Lassa fever vaccine candidate among adults and children in Nigeria, Liberia and Sierra Leone.